Teixeira JP, Hiremath S, Kabli AO, Rewa OG, Clark EG.
Am J Kidney Dis. 2025 Jun;85(6):767-786. doi: 10.1053/j.ajkd.2024.09.015. Epub 2025 Mar 9.
PMID:40072400
Early high-dose continuous veno-venous hemofiltration alleviates the alterations of CD4+ T lymphocyte subsets in septic patients combined with acute kidney injury.
Jin B, Cao D, Yang N, Wang L, Li R, Liu X, Gong P.
Artif Organs. 2022 Jul;46(7):1415-1424. doi: 10.1111/aor.14199. Epub 2022 Feb 17.
PMID:35132659
MECCIAS trial: Metabolic consequences of continuous veno-venous hemofiltration on indirect calorimetry.
Jonckheer J, Demol J, Lanckmans K, Malbrain MLNG, Spapen H, De Waele E.
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P.
Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1.
PMID:37287084
CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study.
Jonckheer J, Spapen H, Debain A, Demol J, Diltoer M, Costa O, Lanckmans K, Oshima T, Honoré PM, Malbrain M, De Waele E.
BMC Nephrol. 2019 Jun 17;20(1):222. doi: 10.1186/s12882-019-1378-y.
PMID:31208356
Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation.
Margraf A, Liu C, Küllmar M, Meersch M, Rossaint J, Zarbock A.
Cells. 2022 Jun 1;11(11):1815. doi: 10.3390/cells11111815.